ID: ALA3675779

Max Phase: Preclinical

Molecular Formula: C14H13N3

Molecular Weight: 223.28

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  Cc1ccc2nc(-c3ccccn3)[nH]c2c1C

Standard InChI:  InChI=1S/C14H13N3/c1-9-6-7-11-13(10(9)2)17-14(16-11)12-5-3-4-8-15-12/h3-8H,1-2H3,(H,16,17)

Standard InChI Key:  NEKDBGWOLPKQKH-UHFFFAOYSA-N

Associated Targets(Human)

Core-binding factor subunit beta 36 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 223.28Molecular Weight (Monoisotopic): 223.1109AlogP: 3.24#Rotatable Bonds: 1
Polar Surface Area: 41.57Molecular Species: NEUTRALHBA: 2HBD: 1
#RO5 Violations: 0HBA (Lipinski): 3HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 11.05CX Basic pKa: 3.00CX LogP: 3.48CX LogD: 3.48
Aromatic Rings: 3Heavy Atoms: 17QED Weighted: 0.69Np Likeness Score: -1.34

References

1.  (2014)  Inhibitors of inv(16) leukemia, 

Source

Source(1):